Beneficient (NASDAQ:BENF) does about 5.49M shares in volume on a normal day but saw 913287 shares change hands in the recent trading day. The company now has a market cap of 4.91M USD. Its current market price is $0.97, marking a decrease of -5.25% compared to the previous close of $1.02. The 52 week high reached by this stock is $51.14 whilst the lowest price level in 52 weeks is $0.72.
Beneficient (BENF) has a 20-day trading average at $1.1508 and the current price is -98.11% off the 52-week high compared with 34.24% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.2459 and its 200-day simple moving average is $3.9989. If we look at the stock’s price movements over the week, volatility stands at 18.99%, which decreases to 14.86% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 38.50 to suggest the stock is neutral.
The consensus objective for the share price is $5.00, suggesting that the stock has a potential upside of 80.6% over the period.
The current price level is -16.02%, -22.43%, and -75.83% away from its SMA20, SMA50, and SMA200 respectively, with the BENF price moving above the 50-day SMA on current market day. Beneficient (BENF) stock is up 6.72% over the week and -23.90% over the past month. Its price is -97.51% year-to-date and -97.90% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year. Expected sales for next quarter are $219k, which analysts say will come at $19.04M for the current fiscal year and next year at $1.05M. In addition, estimates put the company’s current quarterly revenue at an average of $209k.
To reach the target analysts have set, the stock logically needs to grow 80.6 percent from here.
Outstanding shares total 5.08M with insiders holding 20.04% of the shares and institutional holders owning 17.57% of the company’s common stock. The company has a return on equity of -538.85%. The forward price to earnings ratio is 6.04. The beta has a value of -1.09. Price to sales ratio is 4.13.
